Bioanalysis >> About Us >> Events

Events

Sidebar Image

Featured Upcoming Webinar

Considerations for Ligand Binding Assay Platforms:
How to choose the right platform to meet your drug development needs

upcoming webinar - considerations for ligand binding assay platforms
Bioanalytical assays are essential in drug development. In recent years, many new technologies have emerged which offer scientists throughput, sensitivity, multiplexing, and the ability to better understand the data. Given the abundance of new platforms available to meet the most cumbersome and challenging of assays, it is difficult to determine the appropriate applications for these new technologies. In this presentation, we will provide an overview of platforms, case studies, and an evaluation of various new platforms. Here's what you will learn:
  • Understand the differences in platform options in bioanalytical analysis
  • How platforms are designed specifically to meet your performance needs and demands
  • Discuss the Pros and Cons of available platforms
  • Overview of new technologies
  • Review case studies

Past Webinars

Applications of Flow Cytometry in the Drug Development Process
December 7th, 2016

David Lanham, MSc, CBiol, MRSB, Principal Scientific Director, Eurofins Bioanalytical Services

Download Webinar

Matrix Interference in Ligand-Binding Assays: Modern Solutions to an Established Analytical Problem
May 26th, 2016

John Kamerud, PhD., Scientific Director, Eurofins Bioanalytical Services

Download Webinar

Improving Biotherapeutic Peptide Bioanalysis with Advanced Immunoassay Methodologies Webinar
December 9th, 2015

John Kamerud, PhD., Scientific Director, Eurofins Bioanalytical Services

Download Webinar

Accelerating Clinical Flow Cytometry Studies Using Qualified, Modular & Transferrable Immunophenotyping Assays Webinar
November 12th, 2015

David Lanham, MSc, CBiol, MRSB, Principal Scientific Director, Eurofins Bioanalytical Services

Download Webinar

Fit-For-Purpose Biomarker Validation to Support Clinical Trials Webinar
October 28th, 2015

Nann Green, PhD, Principal Investigator, Eurofins Bioanalytical Services

Download Webinar

Development and Evaluation of Ultrasensitive, Fit for Purpose Biomarker Assays using the Singulex® Erenna® Platform
July 29th, 2015

John Kamerud, PhD., Scientific Director, Eurofins Bioanalytical Services

Download Webinar

Case Study: Product Characterization, PK and Immunogenicity Assays for the Development of Biosimilar Trastuzumab
Februrary 18th, 2015

John Kamerud, PhD., Scientific Director, Eurofins Bioanalytical Services

Download Webinar


Upcoming Conferences

Global Engage's 3rd Biologics & Biosimilars Congress: Europe - Berlin, Germany
March 6-7th, 2017 | Booth #2

Schedule a Meeting

CFABS 11th WRIB - LA/Universal City, CA
April 3-7th, 2017

Schedule a Meeting

AAPS National Biotechnology Conference - San Diego, CA
May 1-3rd, 2017 | Booth #605

Schedule a Meeting

Biotrinity - London
March 8-10th, 2017

Schedule a Meeting

Land O'Lakes Bioanalytical Conference - Madison
July 10-13th, 2017

Schedule a Meeting


Posters Presented at Events 

Development of Two Highly Sensitive Singulex Erenna® Methods for the Quantitation of XmAb®14045

Download PDF

Validating Flow Cytometry Assays for Use During Clinical Trial Biomarker Assessments

Download PDF

An ELISA for the Quantitative Determination of Free and Partially Bound Bevacizumab in Human Serum

Download PDF